Head of Patient FIND & AI Strategy

BioMarin Pharmaceutical Inc.; San Rafael (CA); On-site; USD 250,000 - 350,000; Full time

Job summary

BioMarin Pharmaceutical Inc. seeks a Senior Director, Patient FIND to lead the data-driven patient identification function. You will define the scope, hire the team, secure funding, and build the operating model to align commercial, medical, DTA, and R&D leadership.

You will lead an integrated capability with vendor-less architecture, driving cross-disease prioritization and clinical signal definitions while engaging executive stakeholders and ensuring fast, compliant action.

Qualifications

• 12+ years of progressive experience in commercial strategy, analytics, or operations in biotech/pharmaceuticals.
• Proven track record building new functions or operating models from the ground up.
• Deep familiarity with rare disease patient identification and related datasets.
• Experience with healthcare data infrastructure and clinical signal concepts.

Responsibilities

• Define operating model, ownership, and cross-functional interfaces for the Patient FIND function.
• Lead AI-driven capability build, integrating claims, longitudinal data, and unstructured notes.
• Align cross-disease portfolio sequencing with Brand and R&D teams for prioritization.
• Lead organizational design, recruitment, and change management for a new function.
• Engage executives, govern funding, milestones, and ROI across stakeholders.

Skills

Leadership

Strategy

Data analytics

AI in commercial

Executive communication

Stakeholder management

Healthcare data

Rare disease

Team building

Education

Bachelor's degree

Advanced degree preferred

Tools

Komodo Health

HealthVerity

Datavant

EHR/EMR data

Job description

BioMarin Pharmaceutical Inc. seeks a Senior Director, Patient FIND to lead the data-driven patient identification function. You will define the scope, hire the team, secure funding, and build the operating model to align commercial, medical, DTA, and R&D leadership.

You will lead an integrated capability with vendor-less architecture, driving cross-disease prioritization and clinical signal definitions while engaging executive stakeholders and ensuring fast, compliant action.